Fig. 1From: Harnessing the secretome of adipose-derived stem cells in the treatment of ischemic heart diseasesFunctions of the ASC secretome on the ischemic heart. Lots of trophic factors released by ASCs, such as VEGF, HGF, PGF, TGF-β, FGF-2, Ang-1, and Ang-2, IGF-1, and microvesicles, miR-31 and miR-126, benefit for proangiogenesis in the ischemic myocardium. The ASC secretome may have the ability to modulate the release of inflammatory cytokines, such as INF-γ, IDO, NO, IL-6, IL-8, IL-10, IL-11, and TNF-α. ASC-secreted factors such as IGF-1, VEGF, exosomes, and miR-301a may improve the capacity of cardiomyocyte survival in hypoxic conditions. Meanwhile, ASCs may secrete molecules such as VEGF, HGF, MCP-1, TIMP-1, and TIMP-4 that contribute to inhibiting fibrosis and cardiac remodeling. Maybe certain paracrine factors such as SDF-1, VEGF, FGF-2, HGF, CXCL-12, and microvesicles released by ASCs could recruit endogenous stem cells and enable cardiovacular lineage cells re-enter cell cycling. In addition, ASC-conditioned medium could induce conduction slowing of neonatal rat ventricular myocytes (NRVMs), probably attributed to the secondary autocrine myocardial factors released by NRVMBack to article page